Trial intelligence / Profile preview

NV-101 for reversal of soft tissue anesthesia in dental patients

NCT00154167Phase 2Completed

Start
Feb 2003
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in soft tissue anesthesia comparing NV-101 with Placebo (2 arms). Primary endpoint: Time to return of normal sensation in lip, tongue, nose, and chin at 3 hours. Started Feb 2003; status: completed.

02

Drugs

phentolamine
03

Conditions

soft tissue anesthesia

Beyond the preview

Go deeper on NCT00154167.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00154167.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call